Federal Circuit’s en banc MedCo ruling clarifies on-sale bar
In a unanimous en banc decision in The Medicines Company v Hospira, the Federal Circuit addressed and clarified the “on sale” bar, a source of much anxiety for pharmaceutical companies
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: